Additionally, the heatmap depicting the mRNA expression (Figure 1A, bottom part) indicates that most neuroblastoma patients display high levels of MYCN, while the mRNA levels of EGFR, EGF, MAPK1 and CTSD are low or very low. This evidence concerns the gene MYCN and neuroblastoma.